BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30461320)

  • 1. Screening of
    Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
    [No Abstract]   [Full Text] [Related]  

  • 2. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
    Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
    Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
    Yarman S; Ogret YD; Oguz FS
    Genet Test Mol Biomarkers; 2015 Jul; 19(7):394-8. PubMed ID: 25938168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.
    Cai F; Zhang YD; Zhao X; Yang YK; Ma SH; Dai CX; Liu XH; Yao Y; Feng M; Wei JJ; Xing B; Jiao YH; Wei ZQ; Yin ZM; Zhang B; Gu F; Wang RZ
    Eur J Endocrinol; 2013 Dec; 169(6):867-84. PubMed ID: 24050928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
    Cuny T; Pertuit M; Sahnoun-Fathallah M; Daly A; Occhi G; Odou MF; Tabarin A; Nunes ML; Delemer B; Rohmer V; Desailloud R; Kerlan V; Chabre O; Sadoul JL; Cogne M; Caron P; Cortet-Rudelli C; Lienhardt A; Raingeard I; Guedj AM; Brue T; Beckers A; Weryha G; Enjalbert A; Barlier A
    Eur J Endocrinol; 2013 Apr; 168(4):533-41. PubMed ID: 23321498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients.
    Yarman S; Tuncer FN; Serbest E
    Pathobiology; 2019; 86(2-3):128-134. PubMed ID: 30630164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
    Preda V; Korbonits M; Cudlip S; Karavitaki N; Grossman AB
    Eur J Endocrinol; 2014 Nov; 171(5):659-66. PubMed ID: 25184284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study.
    Schöfl C; Honegger J; Droste M; Grussendorf M; Finke R; Plöckinger U; Berg C; Willenberg HS; Lammert A; Klingmüller D; Jaursch-Hancke C; Tönjes A; Schneidewind S; Flitsch J; Bullmann C; Dimopoulou C; Stalla G; Mayr B; Hoeppner W; Schopohl J
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2789-93. PubMed ID: 25093619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
    Vierimaa O; Georgitsi M; Lehtonen R; Vahteristo P; Kokko A; Raitila A; Tuppurainen K; Ebeling TM; Salmela PI; Paschke R; Gündogdu S; De Menis E; Mäkinen MJ; Launonen V; Karhu A; Aaltonen LA
    Science; 2006 May; 312(5777):1228-30. PubMed ID: 16728643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
    Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
    Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues.
    Oriola J; Lucas T; Halperin I; Mora M; Perales MJ; Alvarez-Escolá C; Paz de MN; Díaz Soto G; Salinas I; Julián MT; Olaizola I; Bernabeu I; Marazuela M; Puig-Domingo M
    Eur J Endocrinol; 2013 Jan; 168(1):9-13. PubMed ID: 23038625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
    Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
    Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIP variant causing familial prolactinoma.
    Carty DM; Harte R; Drummond RS; Ward R; Magid K; Collier D; Owens M; Korbonits M
    Pituitary; 2021 Feb; 24(1):48-52. PubMed ID: 33010004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
    Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIP mutation in pituitary adenomas in the 18th century and today.
    Chahal HS; Stals K; Unterländer M; Balding DJ; Thomas MG; Kumar AV; Besser GM; Atkinson AB; Morrison PJ; Howlett TA; Levy MJ; Orme SM; Akker SA; Abel RL; Grossman AB; Burger J; Ellard S; Korbonits M
    N Engl J Med; 2011 Jan; 364(1):43-50. PubMed ID: 21208107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
    Toledo RA; Mendonca BB; Fragoso MC; Soares IC; Almeida MQ; Moraes MB; Lourenço DM; Alves VA; Bronstein MD; Toledo SP
    Clinics (Sao Paulo); 2010 Apr; 65(4):407-15. PubMed ID: 20454499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.
    Ferraù F; Romeo PD; Puglisi S; Ragonese M; Torre ML; Scaroni C; Occhi G; De Menis E; Arnaldi G; Trimarchi F; Cannavò S
    Endocrine; 2016 Dec; 54(3):762-767. PubMed ID: 26815903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.
    Niyazoglu M; Sayitoglu M; Firtina S; Hatipoglu E; Gazioglu N; Kadioglu P
    Pituitary; 2014 Jun; 17(3):220-6. PubMed ID: 23743763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma.
    Matsumoto R; Izawa M; Fukuoka H; Iguchi G; Odake Y; Yoshida K; Bando H; Suda K; Nishizawa H; Takahashi M; Inoshita N; Yamada S; Ogawa W; Takahashi Y
    Endocr J; 2016 Nov; 63(11):953-963. PubMed ID: 27498687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.